Effects of peripheral administration of GH and IGF-I on gene expression in the hippocampus of hypophysectomised rats.


Journal

Neuro endocrinology letters
ISSN: 2354-4716
Titre abrégé: Neuro Endocrinol Lett
Pays: Sweden
ID NLM: 8008373

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 18 09 2018
accepted: 16 12 2018
pubmed: 13 3 2019
medline: 27 4 2019
entrez: 13 3 2019
Statut: ppublish

Résumé

Growth hormone (GH) increases insulin-like growth factor I (IGF-I) production and both hormones affect hippocampal plasticity. We have previously shown that Hbb and Alas2 in the rat hippocampus were robustly regulated by GH-infusions for six days, whereas other transcripts were weakly affected. Here, we explored the effects of prolonged GH administration on transcripts linked to neuroprotection and investigated whether serum IGF-I administration may exert similar effects. Hypophysectomised female rats were infused with GH or IGF-I for 19 days. Hbb, Alas2 and seven additional GH- and IGF-I-related transcripts were quantified by Q-RT-PCR in rat hippocampus. Three transcripts, Hbb, Alas2, and Alox15 were increased by both GH and IGF-I administration. The other transcripts were marginally affected. The 19-day GH-infusion induced similar effects as those reported after 6-day GH treatment, with the addition of the regulation of transcript Alox15. IGF-I induced altered gene expression in relation to its effect on weight gain. This study underlines that there is an entity of transcripts involved in neuroprotection and vascular tone that is regulated by both systemic GH and IGF-I. For other transcripts, the longer duration of this study did not significantly enhance the marginal effects of GH administration seen previously.

Identifiants

pubmed: 30860684
pii: NEL390718A09

Substances chimiques

beta-Globins 0
Insulin-Like Growth Factor I 67763-96-6
Growth Hormone 9002-72-6
Arachidonate 15-Lipoxygenase EC 1.13.11.33
5-Aminolevulinate Synthetase EC 2.3.1.37

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

525-531

Auteurs

Marion Walser (M)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Jan Oscarsson (J)

AstraZeneca Gothenburg, Mölndal, Sweden.

Maria A I Åberg (MAI)

Department of Primary Health Care, Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Johan Svensson (J)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Jörgen Isgaard (J)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

N David Åberg (ND)

Department of Internal Medicine, Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH